LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma

Photo from wikipedia

AP-HP, GHU Paris-Saclay, Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, Le Kremlin Bicêtre, France INSERM, Institut National de la Santé et de la Recherche Médicale Université Paris Saclay… Click to show full abstract

AP-HP, GHU Paris-Saclay, Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, Le Kremlin Bicêtre, France INSERM, Institut National de la Santé et de la Recherche Médicale Université Paris Saclay (COMUE), Le Kremlin-Bicêtre, France CEA, DSV/iMETI, IDMIT, Fontenay-aux-Roses, France Neurology Department, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Hôpital Bicêtre, Le Kremlin Bicêtre, France INSERM U1195 & Paris Saclay University, Le Kremlin Bicêtre, France Faculté de Médecine, Université Paris Saclay, Le Kremlin Bicêtre, France

Keywords: tre france; paris saclay; kremlin bic; bic tre; tre

Journal Title: American Journal of Hematology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.